| Quarterly Financials | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 492 | 588 | 593 | 533 | 627 | 695 | 706 | 732 | 795 | 865 | 855 | 836 | 883 | 975 | 960 | 954 |
| Expenses | 386 | 442 | 448 | 441 | 485 | 523 | 534 | 540 | 595 | 631 | 621 | 629 | 675 | 728 | 706 | 757 |
| EBITDA | 106 | 146 | 146 | 92 | 142 | 172 | 172 | 192 | 199 | 234 | 234 | 207 | 208 | 247 | 254 | 198 |
| Operating Profit % | 21 % | 24 % | 23 % | 15 % | 21 % | 23 % | 23 % | 24 % | 24 % | 25 % | 26 % | 22 % | 22 % | 24 % | 25 % | 19 % |
| Depreciation | 31 | 31 | 33 | 35 | 36 | 37 | 39 | 38 | 40 | 43 | 44 | 46 | 47 | 49 | 49 | 49 |
| Interest | 16 | 17 | 18 | 28 | 19 | 18 | 21 | 21 | 18 | 20 | 18 | 18 | 18 | 16 | 16 | 15 |
| Profit Before Tax | 58 | 98 | 95 | 29 | 87 | 117 | 112 | 133 | 141 | 171 | 172 | 143 | 144 | 181 | 189 | 133 |
| Tax | 16 | 31 | 25 | 12 | 28 | 31 | 32 | 32 | 39 | 45 | 49 | 16 | 37 | 50 | 46 | 32 |
| Net Profit | 42 | 67 | 70 | 18 | 59 | 86 | 81 | 101 | 102 | 125 | 124 | 127 | 106 | 131 | 143 | 101 |
| EPS in ₹ | 5.13 | 13.22 | 2.76 | 0.69 | 2.32 | 3.38 | 3.08 | 3.77 | 3.80 | 4.66 | 4.61 | 4.74 | 3.96 | 4.87 | 5.32 | 3.77 |
Global Health
1,196.60
-13.60
(-1.12%)
Market Cap
32,139.17 Cr
EPS
12.58
PE Ratio
62.62
Dividend Yield
0.04 %
Industry
Healthcare Services52 Week High
1,378.70
52 Week Low
935.50
PB Ratio
9.59
Debt to Equity
0.55
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,130.40 | #1 1,09,890.94 | 98.86 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 51.53 | |
6,901.00 | 99,225.79 | 76.28 | #1 19,165.50 | 14.74 | 917 | 49.14 | 50.68 | |
716.90 | 54,122.95 | 63.40 | 6,931.20 | 8.99 | 645 | -7.43 | 58.47 | |
1,774.60 | 36,265.87 | 44.21 | 5,093.40 | 10.96 | 790 | 3.41 | 45.69 | |
1,196.60 | #5 32,139.17 | #5 62.62 | #6 2,759.20 | #1 25.09 | #6 326 | #10 -20.35 | 49.96 | |
538.95 | 26,921.26 | 73.01 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 52.05 | |
649.50 | 25,989.02 | 69.19 | 2,511.20 | 12.94 | 336 | 48.39 | 51.21 | |
5,836.55 | 14,790.43 | #1 31.63 | 599.90 | 11.69 | 58 | 4.79 | 57.85 | |
1,399.30 | 14,210.13 | 58.71 | 1,334.00 | 10.76 | 218 | 10.57 | 57.52 | |
1,441.30 | 9,450.03 | 49.01 | 1,095.50 | 21.32 | 177 | -0.88 | 49.82 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
25.09 %
Net Income Growth
66.21 %
Cash Flow Change
107.07 %
ROE
10.63 %
ROCE
12.64 %
EBITDA Margin (Avg.)
10.54 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| Total Assets | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,116 |
| Fixed Assets | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 |
| Current Assets | 472 | 489 | 479 | 502 | 812 | 1,580 |
| Capital Work in Progress | 317 | 666 | 382 | 464 | 439 | 327 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 573 | 570 | 582 | 615 | 930 | 1,739 |
| Total Liabilities | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,116 |
| Current Liabilities | 334 | 296 | 358 | 405 | 420 | 573 |
| Non Current Liabilities | 432 | 839 | 959 | 907 | 1,110 | 1,115 |
| Total Equity | 1,217 | 1,296 | 1,350 | 1,382 | 1,616 | 2,428 |
| Reserve & Surplus | 1,136 | 1,214 | 1,268 | 1,300 | 1,565 | 2,375 |
| Share Capital | 81 | 49 | 49 | 50 | 51 | 54 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| Net Cash Flow | -0 | -20 | 3 | 14 | 87 | -78 | 50 | 648 |
| Investing Activities | -126 | -241 | -69 | -249 | -87 | -239 | -421 | -342 |
| Operating Activities | 213 | 228 | 63 | 166 | 175 | 242 | 311 | 645 |
| Financing Activities | -88 | -7 | 9 | 97 | -1 | -81 | 160 | 346 |
Share Holding
| % Holding | Sept 2021 | Oct 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 35.04 % | 35.03 % | 33.08 % | 33.08 % | 33.08 % | 33.07 % | 33.06 % | 33.05 % | 33.04 % | 33.04 % | 33.04 % | 33.03 % | 33.03 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 10.69 % | 0.00 % | 12.09 % | 12.94 % | 12.20 % | 12.47 % | 11.76 % |
| DIIs | 0.00 % | 0.00 % | 7.78 % | 12.55 % | 12.35 % | 10.80 % | 10.93 % | 9.68 % | 10.25 % | 10.57 % | 11.11 % | 10.51 % | 11.93 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 25.44 % | 6.16 % | 5.77 % | 6.79 % | 6.85 % | 6.79 % | 7.14 % | 6.28 % | 6.54 % | 6.74 % | 6.53 % |
| Others | 64.96 % | 64.97 % | 33.69 % | 48.21 % | 48.80 % | 49.34 % | 38.48 % | 50.48 % | 37.47 % | 37.16 % | 37.10 % | 37.24 % | 36.75 % |
| No of Share Holders | 47 | 48 | 2,86,944 | 1,21,407 | 1,07,120 | 1,09,798 | 1,16,627 | 1,24,775 | 1,66,253 | 1,55,307 | 1,49,722 | 1,48,633 | 1,54,688 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 15 May 2025 |  Quarterly Result Announcement | NA | 15 May 2025 | 1,203.60 | 1,241.80 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 1,001.20 | 1,042.50 |
| 14 Nov 2024 | Quarterly Result Announcement | NA | 14 Nov 2024 | 1,073.35 | 1,032.55 |
| 19 Sept 2024 |  Annual General Meeting | NA | 19 Sept 2024 | 1,191.50 | 1,113.90 |
| 03 Aug 2024 |  Extraordinary General Meeting | NA | 03 Aug 2024 | 1,306.70 | 1,209.25 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
5 days agoDeclaration Under Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Investor PresentationMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Key Performance Indicators (Kpis) For FY 2024-25May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
May 15, 2025Amendment In The Code Of Conduct Pursuant To Regulation 8 & 9 Of SEBI (Prohibition Of Insider Trading) Regulation 2015May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
May 15, 2025Results For The Quarter And Financial Year Ended March 31 2025May 15, 2025
May 15, 2025Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI Listing RegulationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Board Meeting Intimation Regarding Approval Of Financial Results For The Quarter And Financial Year Ending March 31 2025 And Recommendation Of Final Dividend.May 05, 2025
May 05, 2025Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI LODR RegulationApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 14, 2025
Apr 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesApr 08, 2025
Apr 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 22, 2025
Mar 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 22, 2025
Mar 22, 2025Announcement under Regulation 30 (LODR)-Credit RatingMar 18, 2025
Mar 18, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 17, 2025
Mar 17, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Mar 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 20, 2025
Feb 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Technical Indicators
RSI(14)
Neutral 49.96
ATR(14)
Less Volatile 33.38
STOCH(9,6)
Neutral 40.55
STOCH RSI(14)
Neutral 62.10
MACD(12,26)
Bullish 0.78
ADX(14)
Weak Trend 16.56
UO(9)
Bearish 59.02
ROC(12)
Downtrend And Accelerating -1.38
WillR(14)
Neutral -41.90
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 HDFC Pharma And Healthcare Fund Direct - Growth | 0 | 0.00% | -1.85% | -1.98% | Apr 2025 | |
 LIC MF Healthcare Fund Direct - Growth | 16694 | 2.37% | -1.13% | -1.44% | Apr 2025 | |
 JM ELSS Tax Saver Fund Direct Plan-Growth | 0 | 0.00% | -1.11% | -1.17% | Apr 2025 | |
| LIC MF Small Cap Fund Direct - Growth | 0 | 0.00% | -0.98% | -1.07% | Apr 2025 | |
 Invesco India Multicap Fund Direct-Growth | 231037 | 0.73% | 0.73% | 0.73% | Apr 2025 | |
| LIC MF Midcap Fund Direct - Growth | 22720 | 0.89% | -0.67% | -0.74% | Apr 2025 | |
 Motilal Oswal Innovation Opportunities Fund Direct-Growth | 65922 | 4.98% | -0.57% | 3.44% | Apr 2025 | |
| JM Aggressive Hybrid Fund Direct-Growth | 56252 | 0.84% | -0.56% | -0.57% | Apr 2025 | |
| Invesco India Smallcap Fund Direct - Growth | 1501706 | 2.90% | 0.41% | 0.44% | Apr 2025 | |
 Navi Nifty Midcap 150 Index Fund Direct - Growth | 0 | 0.00% | -0.32% | -0.33% | Apr 2025 | |
| Invesco India Focused Fund Direct - Growth | 1368138 | 4.43% | -0.21% | -0.22% | Apr 2025 | |
| Invesco India Aggressive Hybrid Fund Direct - Growth | 59135 | 1.08% | 0.16% | 0.27% | Apr 2025 | |
| Invesco India Mid Cap Fund Direct-Growth | 1383806 | 2.74% | -0.13% | -0.29% | Apr 2025 | |
| Invesco India Large & Mid Cap Fund Direct-Growth | 1358479 | 2.40% | -0.13% | -0.23% | Apr 2025 | |
| JM Small Cap Fund Direct - Growth | 76560 | 1.45% | 0.11% | 0.04% | Apr 2025 | |
 PGIM India Multi Cap Fund Direct-Growth | 59095 | 1.94% | -0.11% | -0.18% | Apr 2025 | |
 HSBC Consumption Fund Direct - Growth | 384300 | 3.09% | -0.11% | -0.17% | Apr 2025 | |
| Invesco India Flexi Cap Fund Direct - Growth | 335486 | 1.46% | -0.10% | -0.19% | Apr 2025 | |
| PGIM India Healthcare Fund Direct-Growth | 26471 | 2.95% | -0.09% | -0.20% | Apr 2025 | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 36047 | 1.35% | -0.08% | -0.18% | Apr 2025 | |
| PGIM India Hybrid Equity Fund Direct Plan-Growth | 38540 | 2.19% | -0.08% | -0.05% | Apr 2025 | |
| Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth | 0 | 0.00% | -0.08% | -0.08% | Apr 2025 | |
| LIC MF Aggressive Hybrid Fund Direct-Growth | 48198 | 1.14% | -0.07% | -0.09% | Apr 2025 | |
| PGIM India Large and Mid Cap Fund Direct - Growth | 56526 | 1.04% | -0.06% | -0.10% | Apr 2025 | |
| WhiteOak Capital Quality Equity Fund Direct-Growth | 48460 | 1.40% | 0.06% | -0.02% | Apr 2025 |
About Global Health
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over 30 medical specialties, employed over 1,300 doctors, and had 2,467 installed beds across 4.7 million sq. ft. of area. The company operates hospitals in Gurugram, Indore, Ranchi, Lucknow, and Patna, with specialties including cardiology, neurosciences, oncology, and orthopedics. Global Health Limited went public in November 2022, raising Rs. 2205.57 crores through an IPO. The company has been expanding its facilities, adding beds, doctors, and new medical equipment across its hospitals.
Listing Date
16 Nov, 2022(2 Years,
43 days)
Website
Chairperson NameNaresh Kumar Trehan
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
